Oscar Porras-Perales , Laura Sánchez-Marín , Dina Medina-Vera , María Flores-López , Laura Martín-Chaves , Milena Boccalon , Nerea Requena-Ocaña , Nuria García-Marchena , Raquel Reviriego , Luis J. Santín , Remi Martin-Fardon , Manuel Jiménez-Navarro , Fernando Rodríguez de Fonseca , Antonia Serrano , Francisco Javier Pavón-Morón
{"title":"Sex-specific dysregulation of the CX3CL1/CX3CR1 Axis following cocaine exposure: Translational evidence for a potential biomarker of abstinence","authors":"Oscar Porras-Perales , Laura Sánchez-Marín , Dina Medina-Vera , María Flores-López , Laura Martín-Chaves , Milena Boccalon , Nerea Requena-Ocaña , Nuria García-Marchena , Raquel Reviriego , Luis J. Santín , Remi Martin-Fardon , Manuel Jiménez-Navarro , Fernando Rodríguez de Fonseca , Antonia Serrano , Francisco Javier Pavón-Morón","doi":"10.1016/j.pnpbp.2025.111482","DOIUrl":null,"url":null,"abstract":"<div><div>Cocaine disrupts neurotransmitter systems and promotes neuroinflammation by activating microglia and altering cytokine signaling. The CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 axis is an essential signaling pathway for microglial regulation, may exhibit sex-specific responses to cocaine. In this study, male and female Wistar rats were exposed to acute (5, 15, or 30 mg/kg) or repeated (15 mg/kg/day for two weeks) cocaine. Gene expression of <em>Cx3cl1</em> and <em>Cx3cr1</em> was assessed in the amygdala and hippocampus, alongside plasma CX<sub>3</sub>CL1 concentrations. Additionally, plasma CX<sub>3</sub>CL1 concentrations were assessed in 88 abstinent patients with cocaine use disorder (CUD) and 30 matched healthy controls. Female rats exhibited significantly lower baseline mRNA expression of <em>Cx3cl1</em> and <em>Cx3cr1</em> in both brain regions compared with male rats. Acute cocaine induced dose- and time-dependent transcriptional changes, with female rats exhibiting more pronounced and sustained <em>Cx3cl1</em> and <em>Cx3cr1</em> expression changes compared with males. Repeated exposure produced sex-, region-, and abstinence-dependent regulations of <em>Cx3cl1</em> and <em>Cx3cr1</em>, with persistent downregulation of <em>Cx3cl1</em> and compensatory <em>Cx3cr1</em> upregulation in female rats. In plasma, only male rats exhibited elevated CX<sub>3</sub>CL1 concentrations following cocaine exposure, particularly during early abstinence (<em>i.e.</em>, 2 h–72 h). In humans, overall CX<sub>3</sub>CL1 concentrations did not differ between CUD patients and controls. However, CX<sub>3</sub>CL1 concentrations increased with abstinence duration, particularly in males (<em>r</em> = +0.34, <em>p</em> < 0.01), but not in females. These findings highlight sex-specific regulation of the CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 axis in cocaine-induced neuroinflammation and suggest that plasma CX<sub>3</sub>CL1 concentrations may serve as a potential biomarker or contribute to a composite biosignature, together with other biomolecules, of CUD progression and abstinence. Considering sex differences, may enhance our understanding of addiction pathophysiology and inform targeted therapeutic strategies.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"141 ","pages":"Article 111482"},"PeriodicalIF":3.9000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278584625002362","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Cocaine disrupts neurotransmitter systems and promotes neuroinflammation by activating microglia and altering cytokine signaling. The CX3CL1/CX3CR1 axis is an essential signaling pathway for microglial regulation, may exhibit sex-specific responses to cocaine. In this study, male and female Wistar rats were exposed to acute (5, 15, or 30 mg/kg) or repeated (15 mg/kg/day for two weeks) cocaine. Gene expression of Cx3cl1 and Cx3cr1 was assessed in the amygdala and hippocampus, alongside plasma CX3CL1 concentrations. Additionally, plasma CX3CL1 concentrations were assessed in 88 abstinent patients with cocaine use disorder (CUD) and 30 matched healthy controls. Female rats exhibited significantly lower baseline mRNA expression of Cx3cl1 and Cx3cr1 in both brain regions compared with male rats. Acute cocaine induced dose- and time-dependent transcriptional changes, with female rats exhibiting more pronounced and sustained Cx3cl1 and Cx3cr1 expression changes compared with males. Repeated exposure produced sex-, region-, and abstinence-dependent regulations of Cx3cl1 and Cx3cr1, with persistent downregulation of Cx3cl1 and compensatory Cx3cr1 upregulation in female rats. In plasma, only male rats exhibited elevated CX3CL1 concentrations following cocaine exposure, particularly during early abstinence (i.e., 2 h–72 h). In humans, overall CX3CL1 concentrations did not differ between CUD patients and controls. However, CX3CL1 concentrations increased with abstinence duration, particularly in males (r = +0.34, p < 0.01), but not in females. These findings highlight sex-specific regulation of the CX3CL1/CX3CR1 axis in cocaine-induced neuroinflammation and suggest that plasma CX3CL1 concentrations may serve as a potential biomarker or contribute to a composite biosignature, together with other biomolecules, of CUD progression and abstinence. Considering sex differences, may enhance our understanding of addiction pathophysiology and inform targeted therapeutic strategies.
期刊介绍:
Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject.
Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.